Risk Evaluation of EMT and Inflammation in Metastatic Pancreatic Cancer Cells Following Plasma Treatment

Risk Evaluation of EMT and Inflammation in Metastatic Pancreatic Cancer Cells Following Plasma Treatment

The requirements for new technologies to serve as anticancer agents go far beyond their toxicity potential. Novel applications also need to be safe on a molecular and patient level. In a broader sense, this also relates to cancer metastasis and inflammation. In a previous study, the toxicity of an a...

Full description

Bibliographic Details
Main Authors: Eric Freund, Chiara Spadola, Anke Schmidt, Angela Privat-Maldonado, Annemie Bogaerts, Thomas von Woedtke, Klaus-Dieter Weltmann, Claus-Dieter Heidecke, Lars-Ivo Partecke, André Käding, Sander Bekeschus
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Physics
Subjects:
epithelial-to-mesenchymal transition
kINPen
plasma medicine
plasma sources
reactive oxygen species
ROS
Online Access:https://www.frontiersin.org/article/10.3389/fphy.2020.569618/full

Internet

https://www.frontiersin.org/article/10.3389/fphy.2020.569618/full

Similar Items